Skip to main content
. 2021 Mar 24;60(7):3691–3702. doi: 10.1007/s00394-021-02536-w

Table 4.

Sub-group analysis for the association of 1 egg/week increment and all-cause and CVD mortality in the Moli-sani Study cohort (n = 20,562)

All-cause mortality CVD mortality
N of deaths/n of subjects HR (95%CI) p for interaction N of deaths HR (95%CI) p for interaction
Whole sample 838/20,562 1.06 (1.00–1.12) 271 1.10 (1.01–1.20)
Aged < 65 years 258/16,550 1.05 (0.95–1.16) 0.37 58 1.08 (0.89–1.32) 0.44
Aged ≥ 65 years 580/4012 1.09 (1.03–1.17) 213 1.16 (1.05–1.28)
Women 299/10,905 1.03 (0.94–1.14) 0.19 104 1.19 (1.04–1.36) 0.50
Men 539/9657 1.11 (1.04–1.18) 167 1.11 (0.98–1.24)
Up to lower secondary education 606/10,510 1.06 (1.00–1.13) 0.88 205 1.11 (1.01–1.23) 0.64
Upper secondary/postsecondary 232/10,052 1.05 (0.94–1.16) 66 1.09 (0.88–1.34)
Non-smokers 647/15,665 1.06 (1.00–1.13) 0.89 212 1.09 (0.99–1.21) 0.56
Smokers 191/4897 1.05 (0.94–1.17) 59 1.07 (0.88–1.29)
Physical activity ≤ 30 min/d 306/7402 1.07 (0.97–1.17) 0.49 101 1.10 (0.94–1.28) 0.81
Physical activity > 30 min/d 532/13,160 1.06 (0.99–1.13) 170 1.11 (0.99–1.24)
Normal/overweight 549/14,655 1.07 (1.00–1.14) 0.81 165 1.12 (1.00–1.26) 0.69
Obese 289/5907 1.07 (0.98–1.17) 106 1.09 (0.94–1.26)
Free from diabetes 701/19,501 1.06 (1.00–1.12) 0.82 224 1.09 (0.99–1.20) 0.20
Subjects with diabetes 113/820 1.09 (0.93–1.28) 34 1.26 (0.95–1.65)
Free from hyperlipidaemia 762/19,323 1.06 (1.00–1.12) 0.97 250 1.07 (0.97–1.18) 0.010
Subjects with hyperlipidaemia 66/1092 1.06 (0.86–1.32) 18 1.66 (1.21–2.26)
Free from hypertension 435/15,256 1.03 (0.96–1.11) 0.35 107 1.00 (0.85–1.18) 0.042
Subjects with hypertension 400/5175 1.08 (1.00–1.17) 163 1.15 (1.03–1.28)
Excluding early deaths (follow up > 2 years) 740/20,464 1.06 (1.00–1.12) 233 1.14 (1.01–1.22)

Hazard ratios with 95% CI from the multivariable model adjusted for sex, age (continuous), energy intake (continuous), educational level (categorical), household income (categorical), residence (categorical), smoking (categorical), BMI (categorical), leisure-time PA (categorical), baseline diabetes (categorical), hypertension (categorical), hyperlipidaemia (categorical), and the Mediterranean diet score (continuous)

Missing data: diabetes (n = 241), hypertension (n = 131) and hyperlipidaemia (n = 147)